Core Viewpoint - Guojin Securities maintains a "Buy" rating for Smoore International (06969), projecting EPS for 2025-2027 to be 0.22, 0.39, and 0.59 yuan respectively, with corresponding PE ratios of 67, 37, and 25 times at the current stock price [1] Financial Performance Summary - For Q1-Q3 2025, the company achieved revenue of 10.21 billion yuan, a year-on-year increase of 21.8%, with net profit and adjusted net profit (excluding stock incentive expenses) at 809 million and 1.182 billion yuan, reflecting a year-on-year decrease of 23.8% and an increase of 0.1% respectively [1] - In Q3 2025, the company reported revenue of 4.197 billion yuan, a year-on-year increase of 27.2%, with net profit and adjusted net profit at 317 million and 444 million yuan, showing a year-on-year decrease of 16.4% and an increase of 4.0% respectively [1][2] Business Segment Insights - The HNB (Heated Not Burn) business is expected to significantly contribute to revenue, with the launch of the hilo product in Japan and Poland driving sales growth, alongside increasing regulatory scrutiny on illegal products in Europe and the US [1] - The vaping business is anticipated to achieve double-digit growth in Q3 2025, benefiting from market shifts in Europe and increased enforcement against illegal products in the US [1] - The company is focusing on the iteration and expansion of its own brand series, with a steady increase in market share, and expects favorable growth in its APV (Advanced Personal Vaporizer) business [1][2] Profitability Outlook - Adjusted net profit for Q3 2025 increased by 4.0% to 444 million yuan, with an adjusted net profit margin of 10.6%, down from 11.5% in Q3 2024 [2] - Despite a year-on-year decline in profit margin, the overall performance remains strong, with future profit elasticity expected due to the anticipated increase in profitability from HNB products as sales volume grows [2] - The company is also increasing R&D investments in medical nebulization, with recent FDA acceptance of a subsidiary's abbreviated new drug application indicating progress in this area [2] Market Expansion and Growth Potential - The expansion of the legal vaping market in Europe and the US is a prevailing trend, with the HNB product glo hilo starting promotions in Poland, indicating potential for global sales growth [2] - The company is positioned as a unique player deeply integrated into the supply chains of both vaping and HNB products, suggesting a clear path for future growth [2]